Page 1 of Clinical Trials for Temodar, 475 Total Matches
- 1TerminatedLast Updated: March 22, 2010Condition(s): Primary Glioblastoma Multiforme
- 2Active, not recruitingLast Updated: August 2, 2011Condition(s): Glioblastoma; Gliosarcoma
- 3RecruitingLast Updated: October 10, 2011Condition(s): Glioblastoma Multiforme; Gliosarcoma; Grade IV Malignant Glioma
- 4CompletedLast Updated: January 22, 2009Condition(s): Glioblastoma; Gliosarcoma
- 5Active, not recruitingLast Updated: August 30, 2011Condition(s): Glioblastoma Multiforme; Gliosarcoma; Brain Tumors
- 6Active, not recruitingLast Updated: March 29, 2011Condition(s): Malignant Glioma; Glioblastoma Multiforme; Gliosarcoma
- 7Active, not recruitingLast Updated: July 27, 2011Condition(s): Glioblastoma Multiforme; Gliosarcoma
- 8Active, not recruitingLast Updated: October 10, 2011Condition(s): Glioblastoma; Gliosarcoma; Brain Tumor
- 9Active, not recruitingLast Updated: November 9, 2011Condition(s): Glioblastoma; Gliomas
- 10RecruitingLast Updated: January 19, 2012Condition(s): Glioblastomas
- 11CompletedLast Updated: October 30, 2008Condition(s): Astrocytoma
- 12CompletedLast Updated: November 22, 2011Condition(s): Glioblastoma
- 13Enrolling by invitationLast Updated: March 14, 2011Condition(s): Glioma; Astrocytoma
- 14RecruitingLast Updated: September 26, 2011Condition(s): Melanoma
- 15CompletedLast Updated: January 22, 2009Condition(s): Glioblastoma; Gliosarcoma
- 16Not yet recruitingLast Updated: August 27, 2007Condition(s): Glioblastoma
- 17TerminatedLast Updated: January 12, 2012Condition(s): Glioblastoma Multiforme
- 18Active, not recruitingLast Updated: December 26, 2008Condition(s): Glioblastoma; Gliosarcoma
- 19Active, not recruitingLast Updated: September 19, 2011Condition(s): Glioblastoma; Gliosarcoma; Anaplastic Astrocytoma
- 20CompletedPH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant GliomasLast Updated: August 1, 2011Condition(s): Gliosarcoma; Glioblastoma; Anaplastic Astrocytoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Temodar
